Skip to main content
. 2020 Dec 7;11:595735. doi: 10.3389/fendo.2020.595735

Table 1.

Clinic, therapy, and glycemic control parameters in children and adolescents with T1D.

Variable/Observation period T0 T1 p
Gender (Males/Females) (%) 31/31 (50/50) 31/31 (50/50)
Age (years) 11.1 ± 4.37 (10.9) 11.4 ± 4.37 (11.2) <0.0001
T1D time disease (years) 4.89 ± 4.23 (3.67) 5.19 ± 4.22 (3.97) <0.0001
Puberty (NO/YES) (%) 34/28 (54.8/45.2) 34/28 (54.8/45.2)
Insulin delivery method (MDI/CSII) (%) 33/29 (53.2/46.8) 33/29 (53.2/46.8)
Meal-Time insulin (IU/kg/day) 0.40 ± 0.14 (0.38) 0.40 ± 0.13 (0.38) 0.546
Basal insulin (IU/kg/day) 0.32 ± 0.13 (0.33) 0.34 ± 0.13 (0.34) 0.027
TDD insulin (IU/kg/day) 0.72 ± 0.22 (0.73) 0.74 ± 0.19 (0.77) 0.186
Physical Activity (h/week) 3.27 ± 2.82 (2.00) 0.24 ± 0.59 (0.00) <0.0001
GMI (%); (mmol/mol) 7.45 ± 0.74 (7.40); 57.9 ± 8.13 (57.4) 7.35 ± 0.72 (7.25); 56.9 ± 7.89 (55.7) 0.069; 0.071
GMI ≤7.0% (YES/NO) (%) 22/40 (35.5/64.5) 21/41 (33.9/66.1) χ2 = 34.9; p <0.0001
Average glucose (mg/dl) 167.4 ± 21.6 (166.0) 164.6 ± 21.1 (162.0) 0.058
SD glucose (mg/dl) 60.8 ± 11.8 (61.5) 57.6 ± 10.8 (58.0) <0.0001
%CV (%) 36.3 ± 5.31 (36.1) 34.9 ± 4.90 (34.0) 0.001
TBR<70 (%); TBR<54 (%) 2.63 ± 2.37 (1.85); 0.50 ± 0.63 (0.30) 2.13 ± 2.41 (1.45); 0.34 ± 0.53 (0.20) 0.001; 0.002
TIR70-180 (%) 60.0 ± 13.1 (60.5) 62.1 ± 13.7 (63.5) 0.008
TAR>180 (%); TAR>250 (%) 37.8 ± 13.9 (37.3); 11.4 ± 7.77 (10.0) 35.7 ± 14.4 (34.1); 9.74 ± 7.00 (8.95) 0.048; <0.001
Sensor usage (%) 92.0 ± 11.3 (96.5) 91.8 ± 12.1 (96.5) 0.755

Continuous data are reported as mean ± SD (median) ; categorical as absolute frequencies (percent values).

CSII, continuous subcutaneous insulin infusion; CV, coefficient of variation; GMI, glucose management indicator; MDI, multiple daily injections; SD, standard deviation; T1D, type 1 diabetes; TAR, time above range; TBR, time below range; TDD, total daily dose; TIR, time in range.